Replies to post #330495 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

The good news is that biotech should be relatively immune over the long run

Maybe the next application for the mRNA technology.

[blue finch]

Collapse or correction
Big difference

A10-15 % correction occurs every so often and hasn’t occurred in a long time


Best of luck to the Avxl longs

We haven’t seen bad news
Or proof their drug doesn’t work

Testing takes a lot of time